Tag Archives: shortage

Millions at risk from cholera due to lack of clean water, soap and toilets, and shortage of cholera vaccine – World Health Organization (WHO)

  1. Millions at risk from cholera due to lack of clean water, soap and toilets, and shortage of cholera vaccine World Health Organization (WHO)
  2. Cholera now threatens 1bn people. It’s time to finish what we began in the 19th century The Guardian
  3. Global cholera outbreaks deeply linked to climate change: WHO official Anadolu Agency | English
  4. Cholera Vaccine Shortage Puts Millions of Children At-Risk Precision Vaccinations
  5. SOUTHERN AFRICA: A FOUR-FOLD SURGE IN CHOLERA CASES PUTS TENS OF THOUSANDS OF CHILDREN AT RISK AS CYCLONE SEASON BRINGS MORE FLOODING Save the Children International

Read original article here

To fight climate change and housing shortage, Austin becomes largest U.S. city to drop parking-spot requirements – The Texas Tribune

  1. To fight climate change and housing shortage, Austin becomes largest U.S. city to drop parking-spot requirements The Texas Tribune
  2. City Council postpones implementation of rules directed by new state law that will likely lead to fewer parks KXAN.com
  3. Young Parents, UT Students Support Zoning Changes at Historic Meeting Austin Chronicle
  4. Austin City Council votes to eliminate parking mandates from land development code KVUE.com
  5. Austin City Council: Minimum parking requirements on Thursday agenda Austin American-Statesman
  6. View Full Coverage on Google News

Read original article here

McDonald’s McRib is back. It was born thanks to a McNuggets shortage. – The Washington Post – The Washington Post

  1. McDonald’s McRib is back. It was born thanks to a McNuggets shortage. – The Washington Post The Washington Post
  2. McDonald’s McRib is back from the dead—just in time for Halloween. Here’s why the pork sandwich is an undead fan favorite Yahoo Finance
  3. The McRib is BACK…. (again!) We weigh in on a controversial classic WTOL11
  4. Customers slam McDonald’s latest revival saying ‘no one asked for this’ and demand return of another favor… The US Sun
  5. McRib Is Making a Comeback—When To Expect Its Triumphant Return Parade Magazine
  6. View Full Coverage on Google News

Read original article here

Texas governor’s taskforce takes on teacher shortage crisis in new report – KXAN.com

  1. Texas governor’s taskforce takes on teacher shortage crisis in new report KXAN.com
  2. Texas Teacher Vacancy Task Force report calls for better pay, training The Dallas Morning News
  3. Texas’ teacher shortage task force calls for pay raises, more training The Texas Tribune
  4. How can Texas keep more teachers in classrooms? Here’s what a state committee found. Fort Worth Star-Telegram
  5. Texas teachers need raises, more training and better working conditions to fix shortages, state task force finds KPRC Click2Houston
  6. View Full Coverage on Google News

Read original article here

Egg shortage sends New Zealanders rushing to buy their own hens


Hong Kong
CNN
 — 

Eggs have soared in cost around the world over the past year as avian flu decimated chicken flocks and fallout from Russia’s war with Ukraine raised the prices of energy and animal feed.

In the United States, egg prices have far surpassed the increase in other grocery items, soaring nearly 60% in the 12 months to December compared to the year before. In Japan, wholesale prices have reached a record high.

In New Zealand, which consumes more eggs per person than most countries, the squeeze has been exacerbated by a change in farming regulations. And rising costs have sparked a frenzy, with people hunting for hens online so they can secure their own supplies of the pantry staple.

On Tuesday, popular local auction site Trade Me told CNN that searches for chickens, and equipment related to caring for them, had spiked 190% so far this month, compared to the same period a month ago.

“Since the start of January, we have seen over 65,000 searches for chickens and other chicken-related items, like feeders, coops and food,” said Millie Silvester, a spokesperson for the company.

The shortage has also caused a particularly acute headache for bakers in the country.

“All the public are now trying to buy chickens for home because they can’t get eggs,” said Ron van Til, a bakery owner near the city of Christchurch, who has had to adjust how he makes his cakes and muffins.

Van Til said his sister was selling “four brand new chickens” on auction through Trade Me, fetching more than double the usual price.

The trend has prompted animal welfare advocates to warn against making impulse buys.

“Chickens live for a long time,” said Gabby Clezy, CEO of the Society for the Prevention of Cruelty to Animals (SPCA) in New Zealand. “They live from eight to 10 years, sometimes even longer depending on the breed.”

Clezy also noted that hens do not produce eggs their entire lives, and their laying habits are dependent on factors including their age and local climate.

“So if people are getting chickens solely because [they think] they’ll have a permanent supply of eggs, that just isn’t the case,” she said. “We’re asking people to consider them as companion animals, which they are.”

Trade Me has also urged customers on its marketplace to think through any purchases.

“It’s important that our members are aware of the responsibilities that come with owning chickens, and are well set up to care for them,” Silvester said in a statement.

Health experts are weighing in, too. According to the US Centers for Disease Control and Prevention (CDC), anyone signing up for a backyard coop should take special care when handling the animals and their eggs, particularly because of the risk of germs associated with salmonella.

New Zealand’s egg shortage has been linked to a long anticipated change in farming law, which took effect on January 1 this year.

The law prohibits the production of eggs from chickens kept in conventional or “battery cages” — typically cramped metal spaces that do not provide adequate welfare for hens, according to SPCA.

That’s why in 2012, the government announced a ban on such facilities.

But “a 10-year transition period away from conventional cages was introduced, to allow egg producers time to shift farming practices,” Peter Hyde, a representative for New Zealand’s Ministry for Primary Industries, told CNN in a statement when asked about the current shortage.

 “Egg producers had the option to move to colony cages, barns and free-range systems,” added Hyde, the ministry’s acting national manager of animal welfare and national animal identification and tracing compliance.

Hyde said that over the last 18 months, the ministry had “been in regular contact with operators, and visited farms needing to transition.”

Even with the long lead time, however, the ban has caused supply snags, according to some businesses.

Foodstuffs, a New Zealand supermarket chain, recently placed temporary limits on how many eggs each customer can buy.

“It’s a significant change for the egg supply industry,” Emma Wooster, the company’s head of public relations, told CNN in a statement. “We’re working with egg suppliers to increase our offer in other types of eggs.”

Countdown, another major grocery retailer, said while it did not currently have limits on egg sales, it would encourage customers to “only buy what they need” to ensure enough supply for everyone.

Other businesses have been forced to switch things up.

Van Til, the bakery owner, said his team had swapped out fresh eggs in recipes for alternative ingredients.

The longtime owner of Rangiora Bakery has seen wholesale prices for fresh eggs shoot up about 50% compared to four months ago, leading him to buy more dried eggs instead.

Van Til also pointed to changes at other local eateries, saying some cafes had started taking certain dishes off their menus so “instead of having five breakfast items [with] eggs, you might only have two.”

“And the customer hopefully will pick up pancakes or waffles,” he added. “Or whatever other offerings you come up with.”

Read original article here

Abbott Labs under criminal investigation over baby formula shortage: Report

The Justice Department is investigating Abbott Laboratories’ baby formula plant in Michigan, which was at the center of a nationwide formula shortage that plagued millions of families, the Wall Street Journal reports. 

In May, Abbott reached an agreement with the Food and Drug Administration (FDA) to reopen the company’s manufacturing plant in Sturgis, Michigan to help ease a nationwide shortage of baby formula, after the facility was closed due to bacterial contamination.

Shelves with baby formula are pictured at Skippack Pharmacy with a shopper limit amid continuing nationwide shortages in Schwenksville, Pennsylvania, U.S., June 2, 2022.  (Reuters Photos)

Shelves typically stocked with baby formula sit mostly empty at a store in San Antonio, Tuesday, May 10, 2022. Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading (AP Photo/Eric Gay / AP Newsroom)

FDA Commissioner Robert Califf said Abbott, under the conditions of the agreement, would correct insanitary conditions that led to the contamination and plant closure.

“The DOJ has informed us of its investigation, and we’re cooperating fully,” an Abbott spokesman told the Wall Street Journal.

‘SKY-HIGH EGG PRICES: A HISTORICAL LOOK AT EGG COSTS SINCE 1980

The investigation signals further scrutiny of Abbott’s operation of the plant, a major source of baby formula in the U.S.

An Abbott Laboratories manufacturing plant is shown in Sturgis, Mich., on Sept. 23, 2010. (Brandon Watson/Sturgis Journal via AP / AP Newsroom)

Yury Navas, 29, of Laurel, Md., kisses her two-month-old baby Jose Ismael Gálvez, at Superbest International Market in Laurel, Md., Monday, May 23, 2022, while looking for formula. (AP Photo/Jacquelyn Martin / AP Newsroom)

Last January, FDA inspectors found the cronobacter pathogen at the plant after receiving reports of babies who drank the company’s formula and became sick. The bacteria that was detected in the supply found let to at least four infant illnesses-including two deaths. 

KROGER CEO SAYS HALF ITS CUSTOMERS ARE UNDER FINANCIAL STRAIN 

The inspectors also found standing water, damage to drying equipment and defects in the seams of formula cans, among other problems at the Sturgis plant. 

A woman shops for baby formula at Target in Annapolis, Maryland, on May 16, 2022, as a nationwide shortage of baby formula continues due to supply chain crunches tied to the coronavirus pandemic that have already strained the countrys formula stock, (Photo by Jim Watson/AFP via Getty Images / Getty Images)

In a 10-page report published in September, the FDA stated that conditions observed at the Abbott facility “were not consistent with a strong food safety culture.”

Abbott temporarily halted production at the Sturgis factory in February, and recalled baby formula made at the plant.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

The move sparked a national formula shortage which forced the U.S. to airlift millions of pounds of powdered formula from overseas.

Read original article here

Type 2 diabetes drug Ozampic is facing shortage after approved by FDA as weight loss drug Wegovy

Monday, January 16, 2023 1:57AM

Demand for a diabetes drug is on the rise, but the reason for that demand is being called into question.

The drug semaglutide was initially marketed under the name Ozempic to manage type 2 diabetes, but last year, it was approved by the FDA to be used for weight loss under the name Wegovy.

But now, the drug manufacturer Novo Nordisk is struggling to meet demand, which doctors say is creating a problem for type 2 diabetes patients.

RELATED: National Diabetes Awareness Month: Knowing signs and symptoms

“Our patients with diabetes are struggling just to get their medications to control their blood sugars and so we’re having to substitute other medications, increase their insulin requirements. People are gaining weight back from not being on these medications and so it really is becoming a problem for our patients that are dealing with type 2 diabetes. But then again, there is an epidemic of obesity, as well and we need to treat the obesity to prevent the diabetes in the first place,” said Dr. Disha Narang.

According to the CDC, more than 37 million Americans have diabetes 90% to 95% of them have type 2 diabetes.

Read original article here

Ozempic Shortage – Demand for Diabetes Weight Loss Drugs 2023

If there is one thing you can count on, it’s that human beings will always jump on a weight loss bandwagon. Remember Fen Phen? Atkins? Olestra? Trends come and go but evidently our collective desire for svelte, taut bodies is constant—which is why 2022 may well be remembered as the year of Ozempic. Right now, no social gathering or midnight TikTok scroll is complete without at least one mention of the ubiquitous, and controversial, drug. Ozempic’s sudden popularity—driven, in part, by the celebrities who have touted it—have made it the Botox of weight loss.

“There is a big influx of patients coming asking for it by name,” says Jamie Gabel, PA-C, of Advitam at the Shafer Clinic in New York City. “They know what it’s called, they know what it does, and they’re asking for it specifically before anything else.” That, he observes, is a new phenomenon that’s only started in the last few months.

A quick refresher: Ozempic is the brand name (like Tylenol) for a GLP1 agonist peptide called semaglutide, which helps the pancreas produce insulin. It was originally developed, and FDA-approved in 2017, for the treatment of type 2 diabetes, but a side effect of the drug is appetite suppression and weight loss, which is why it’s now being used by non-diabetics as the silhouette-reducing aid du jour, despite possible serious side effects like nausea and other gastrointestinal issues.

Off-label uses for drugs are nothing new, but here’s the rub: the increased demand for Ozempic has left both local pharmacies and Novo Nordisk, the manufacturer, clamoring to keep up. Which means that diabetics who need the drug to treat their disease are having a harder time getting it—and those that can may find the price tag to be way higher, especially if they’re not going through insurance. Market watchers theorize that the run on Ozempic actually began when supplies of Wegovy—a semaglutide preparation that is specifically prescribed for weight loss—began to run low, prompting many to shift to off-label use of Ozempic instead. Add a Tiktok hashtag or two, and you have a viral sensation situation in which supply simply cannot keep up with demand.

Thankfully, there are effective alternative medications for those who have been using Ozempic for diabetes treatment. And for those who want to give it a shot to help shed a few extra pounds? The best answer is to wait. Both Novo Nordisk and pharmacies “are working on it,” says Gabel. Wegovy is set for a robust relaunch in 2023, supplies of Ozempic are expected to stabilize by March, and competitors waiting in the wings with similar drugs are slated to hit the market within the next few months. The year of Ozempic? It may well turn out to be an era.

Garrett Munce writes about men’s style and grooming. He’s written for Esquire, New York Magazine, Spotlyte, and Very Good Light and held staff positions at GQ and W. Follow his skincare obsession on Instagram at @garrettmunce.

Read original article here

2022 in GPUs: The shortage ends, but higher prices seem here to stay

Enlarge / From left to right and largest to smallest: GeForce RTX 4080 (which is the same physical size as the RTX 4090), Radeon RX 7900 XTX, and Radeon RX 7900 XT.

Andrew Cunningham

In 2021, the biggest story about GPUs was that you mostly just couldn’t buy them, not without paying scalper-inflated prices on eBay or learning to navigate a maze of stock-tracking websites or Discords.

The good news is that the stock situation improved a lot in 2022. A cryptocurrency crash and a falloff in PC sales reduced the demand for GPUs, which in turn made them less profitable for scalpers, which in turn improved the stock situation. It’s currently possible to visit an online store and buy many GPUs for an amount that at least gets kind-of-sort-of close to their original list price.

We also saw lots of new GPU launches in 2022. The year started off less-than-great with the launch of 1080p-focused, price-inflated cards like Nvidia’s RTX 3050 and AMD’s inspiringly mediocre RX 6500 XT. But by the end of the year, we received Nvidia’s hugely expensive but hugely powerful RTX 4090 and RTX 4080 cards, AMD’s less-monstrous but still competitive RX 7900 series, and Intel’s flawed but price-conscious Arc A770 and A750 cards.

The bad news is that the aftereffects of the GPU shortage still linger, mainly in the form of inflated prices. We can hope that these come down in 2023, but so far, there is little sign of that happening.

Budget GPUs are in a sad state

You can still find GPUs at and under $200 if you’re looking for basic, better-than-integrated performance in older and lower-end games that you’ll mostly run at or below 1080p.

But performance in this category has moved very little over the last three or four years. Nvidia seems content to serve this low-end slice of the gaming market with the same GeForce GTX 1650 GPU it introduced in 2019, a card that continues to stubbornly hover in the $150-to-$200 price window despite its age. AMD and Intel have both released new cards for the sub-$200 market in the last year, and those cards can sometimes beat the GTX 1650’s performance. But these cards are also flawed in some hard-to-ignore ways.

AMD’s RX 6500 XT was originally a laptop GPU that was adapted for desktops, and as a result, it supports fewer displays than other GPUs in the RX 6000 series, it’s missing hardware video encoding support, and its performance in older PCI Express 3.0-capable PCs is poor because it only provides four lanes of PCIe bandwidth in the first place. Intel’s Arc A380 has great video encoding support (including for the AV1 video codec), but like other Arc cards, its drivers are rough around the edges, and performance in older games can be spotty.

If superior GPUs like Nvidia’s RTX 3050 series and AMD’s RX 6600 series drop down into the $200-and-under range soon, we’ll be feeling a lot better about the state of budget GPUs (the RX 6600 is getting awful close, with prices falling into the $220-250 range for some models depending on the sale). Those GPUs still come with compromises, like mediocre ray-tracing performance and a more hit-or-miss experience at resolutions above 1080p, but it’ll be nice to put the GTX 1650 firmly in the rear-view.

For the best GPUs, $1,000 and up is the new normal

Enlarge / Nvidia’s hefty RTX 4090 GPU also has a hefty $1,600 price tag, and you’ll pay more than that to actually buy the GPU right now.

Sam Machkovech

Shifting to the other extreme of the market, it used to be that GPUs with four-digit price tags were mostly ignorable by normal people. Halo products like Nvidia’s Titan GPUs performed well, sure, but why pay all that money when cheaper xx80 and xx70-series GPUs could give you a large percentage of that performance for a small percentage of the price?

The story of this generation’s midrange cards still has yet to be written, but so far, the high-end cards in the RTX 4000 series and the RX 7000 series have been listed for much more than their predecessors. The $1,200 RTX 4080 is a huge jump from the $700 Nvidia originally advertised for the RTX 3080 and 2080. If the newly rebranded 4070 Ti launches at $900 as is currently rumored (and was originally planned, back when it was called the “RTX 4080 12GB”), that will be a substantial hike over the $500-to-$600 launch prices of cards like the RTX 2070, RTX 3070, and RTX 3070 Ti.

All of these prices are made much worse by the fact that you can’t find RTX 4080 or 4090 cards anywhere close to their launch MSRPs right now.

Things look marginally less exorbitant on AMD’s side, where the top-tier RX 7900 XTX launched for the same $999 price as last-generation’s top-tier RX 6900 XT did. But where the 6900 XT was accompanied by an RX 6800 XT that provided most of the performance for $649, the 7900 XTX’s little sibling is an $899 RX 7900 XT that actually gives you less performance-per-dollar than the XTX. Both cards still undercut Nvidia’s pricing for the RTX 4000 series, but that’s more about how expensive the 4090 and 4080 are than it is about the value AMD is providing.

Nvidia CEO Jensen Huang said that these higher prices are here to stay, courtesy of the increased costs associated with designing and manufacturing these GPUs. Obviously, Huang is not an impartial observer here—he is materially invested in keeping the prices of his GPUs high, especially as Nvidia’s finances have suffered. But there’s some truth to what he’s saying: cutting-edge manufacturing processes are expensive, Nvidia is fighting AMD, Apple, and all kinds of other chip designers for TSMC’s production capacity, and gigantic monolithic chips like the RTX 4000 GPUs are going to have lower yields than smaller, less-complex processor dies.

Read original article here

The Diabetes Drug Becomes A Viral Weight Loss Hit (Elon Musk Boasts Using It) Creating A Shortage

Topline

Ozempic, the “worst kept secret in Hollywood,” has become increasingly popular due to its weight loss results—hyped even by billionaire Elon Musk—causing a shortage, even though it’s really meant for use in patients with type two diabetics.

Key Facts

Ozempic (known generically as semaglutide) is an injection used to lower blood sugar and hemoglobin A1C (the part of red blood cells with glucose attached) in type two diabetics; low A1C levels decrease diabetes complications like stroke, high blood pressure and blindness.

Manufactured by Novo Nordisk, the drug is a glucagon-like peptide-1 (GLP-1) receptor antagonist (a class of drugs used to treat diabetes) that was first approved for use in type two diabetics in 2017.

To lower blood sugar and A1C, the drug reacts with the body in three ways by helping the pancreas produce more insulin when blood sugar is high, slowing down the process of food leaving the stomach and stopping the liver from making and releasing too much sugar.

It’s meant to be injected once weekly in either the thigh, stomach or upper arm, with or without meals at any time of day, and patients typically start out taking a dose of 0.25 mg, though after four weeks it’s bumped up to 0.5 mg and then up to 1 mg if “more glycemic control is needed.”

Out of the more than 37 million Americans with diabetes, the vast majority—between 90% to 95%— have type two diabetes, according to the Centers for Disease Control and Prevention.

One of the side effects of Ozempic is weight loss, so some doctors have been prescribing the drug as an off-label use (the unapproved use of an approved drug) for weight loss in those without diabetes—Ozempic has not been approved by the FDA as a weight loss drug.

A study published in The New England Journal of Medicine found those who took Ozempic for 68 weeks, paired with a reduced calorie diet and a more active lifestyle saw an average change of body weight of 14.9% compared to a 2.4% change in the placebo group.

These findings have caused both obese people and those slightly overweight to request Ozempic prescriptions from their doctors.

Although Ozempic isn’t approved for weight loss, Wegovy, a higher-dose version of Ozempic, was approved for weight loss by the U.S. Food and Drug Administration in 2021 for obese or overweight adults with at least one weight-related condition like diabetes or high blood pressure.

News Peg

Wegovy and Ozempic are both listed by the FDA as two of almost 200 medications in a supply shortage, their recent rise in popularity for weight loss is believed to be the reason for their shortage. Francisco Prieto, a California-based physician told the Los Angeles Times that due to the shortage, his patients who take Ozempic have to “call multiple pharmacies and drive around town to see if it’s in stock,” with some still not being able to fill their prescriptions.

Chief Critic

According to the chief of clinical nutrition at the David Geffen School of Medicine at UCLA, Dr. Zhaoping Li, people should be wary of using diabetes drugs for weight loss. “The issue is that this is one of the tools in our box, it is not the end-all,” he told Variety. “The longest study done on these injections was conducted over less than two years. A lot of questions have not been answered.”

Side Effects

Some of the most common side effects that Ozempic causes are nausea, diarrhea, constipation and stomach pain. However, more serious side effects may occur, like possible thyroid tumors and cancer. According to Novo Nordisk, if someone takes the drug and feels a shortness of breath, a lump or swelling in the neck, trouble swallowing or hoarseness, they should contact their primary care doctor.

Tangent

Ozempic and other diabetes drugs like Mounjaro have made their way around Hollywood, with different celebrities and influencers boosting their weight loss as a result of the drugs. For example, when someone pointed out Elon Musk’s weight loss on Twitter in October, Musk responded that he achieved the look through fasting “and Wegovy.” His comment was met with a mixture of praise and criticism, with someone bringing up the drug shortages, claiming Musk didn’t “need it for weight loss, diabetics ACTUALLY need it.” According to Variety, the drugs have “devotees from every corner of the industry,” with actors, executives and agents alike glorifying them on Signal, an encrypted instant messaging service used to hold confidential conversations. Even just speculation is enough to draw controversy, and hashtag #ozempic has over 350 million views on TikTok. Thousands of videos are posted with the hashtag with people sharing their weight loss journeys and before and after pictures, with some attributing the drug’s rise in popularity on the app to its supply shortage.

Further Reading

What Is Ozempic and Why Is It Getting So Much Attention? (New York Times)

Hollywood’s Secret New Weight Loss Drug, Revealed: The Hype and Hazards of Ozempic (Variety)

TikTok trend wipes out Ozempic supply, leaving people with diabetes dizzy, scared (Los Angeles Times)



Read original article here